1 2 3 Three types of alkaloid. Isolysergic acid is optical isomer of lysergic acid. Clavine is without 9-10 double bond and carboxyl. 4 Vasoconstrictors! Dihydroergotamine is without 9-10 double bond and is intended for nasal administration (rapid onset) 5 Vasodilators! 6 causes selective vasodilation in lungs 7 weak αlpha2 antagonist as well – risk of reflexive tachycardia 8 Prazosin is not in clinical use, other derivatives posses better safety profiles. Terazosin and doxazosin has longer biological half-time (use 1x a day). Therapy of hypertension and benign prostatic hyperplasia (BPH) 9 Selective decrease of urethral and prostatic tonus. Therapy of BPH 10 Urapidil is both alpha1 antagonist and central 5HT1A agonist – combined central and peripheral antihypertensive effect Tamsulosin selectively decreases urethral and prostatic tonus, improves bladder function 11 Alkaloid of Yohimbe tree 12 13 14 R1 is substituted with lipophillic group – isopropyl, tert-butyl or arylalkyl – selectivity towards beta receptors 15 Same space orientation but different R/S name! Different groups priority! 16 Non-cardioselective betablockers are contraindicated in cardiology (use only for migrain and glaucoma therapy) 17 Metipranolol – obsolent in cardiology; use for migraine prevention, stress urinary incontinence Cloranolol, Bufetolol – similar properties, less common 18 Propranolol is used in migraine prevention Indenalol less common, same use 19 Carteolol – local application for glaucoma therapy Nadolol – angina pectoris therapy Bunolol / Levobunolol (pure S isomere) – local application in glaucoma therapy Tertatolol – used for hypertension therapy 20 Local application in glaucoma therapy 21 Pindolol and Bopindolol (prodrug converted to dimethylpindolol) used for hypertension therapy. Use limited to angina pectoris therapy now. 22 Lipophillic compound passes through blood-brain barrier. Therapy of arrhythmias, angina pectoris 23 lipophillic compounds passes through blood-brain barrier – cerebral side-effects. Alprenolol was used for hypertension, penbutolol for angina pectoris therapy. Obsolent today. 24 Atenolol is used for angina pectoris, myocardial infarction, arrhythmia and hypertension therapy. Metoprolol is widely used in same indications as atenolol, additionaly for migraine prevention Betaxolol posses some additional Ca2+ channel blocking effect – used for therapy of glaucoma, angina pectoris and hypertension Talinolol was used as antihypertensive agent. 25 Celiprolol possess partial beta2 agonistic and alpha2 antagonistic effect. Used for hypertension and angina pectoris therapy. Acebutolol is used for angina pectoris and arrhythmia therapy 26 Nebivolol possess direct vasodilating effect (nitrate-like effect). Therapy of angina pectoris, heart insufficience. 27 Used as antihypertensive and antiarrhythmic agent. 28 Bisoprolol possess long biological half-time (allows 1x day administration). Used against angina pectoris, arrhythmias, hypertension. Used in long term arrhythmia profylaxion, after myocardium infarction. Bevantolol posses additional alpha agonistic and Ca2+ channel blocking activity (due to dimethoxy phenylethyl group). No renal side effects- suitable for patients with renal insufficience. Used for treatment of angina pectoris, arrhythmias, hypertension. 29 Short acting betablockers. Continual intravenous infusion application. Esmolol – biological half-time 9min, end of effect up to 30 min. Use in acute medicine for treating tachyarrhythmias and during myocardial infarction. Flestolol – biological half-time 6min, not in clinical use. 30 Labetalol – not selective beta and selective alpha1 blocker. Only intravenous application. Hypertension crisis therapy, gravidity hypertension therapy. Carvedilol – complex cardiovascular effect. non selective beta, but higher affinity for blocking of beta1. Selective alpha1 blocker. Best mortality index, remedy of first choice. Therapy of heart insufficience, angina pectoris, heart ischaemia and hypertension. 31 Non selective beta, selective alpha1 blocker. Used widely in Japan and South Korea. 32 II. + III. class of antiarrhythmic agents (K+ channel blocker, non selective beta blocker). Used for therapy of tachyarrhythmias. 33